Discontinuation report AURALGAN
| Report ID | 165407 |
| Drug Identification Number | 02332477 |
| Brand name | AURALGAN |
| Common or Proper name | AURALGAN |
| Company Name | PALADIN LABS INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ANTIPYRINE BENZOCAINE |
| Strength(s) | 54MG 14MG |
| Dosage form(s) | SOLUTION |
| Route of administration | OTIC OTIC |
| Packaging size | 14mL |
| ATC code | S02DA |
| ATC description | OTHER OTOLOGICALS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-07-25 |
| Remaining supply date | 2021-11-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | No remaining supply |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-07-26 | English | Compare |
| v2 | 2022-07-25 | French | Compare |
| v1 | 2022-07-25 | English | Compare |
Showing 1 to 3 of 3